Drug Profile
R-verapamil
Alternative Names: D 1411Latest Information Update: 13 Jan 1997
Price :
$50
*
At a glance
- Originator Celltech Group
- Class Analgesics; Antiarrhythmics; Antihyperglycaemics; Antihypertensives; Antineoplastics; Irritable bowel syndrome therapies; Ischaemic heart disorder therapies; Nitriles; Phenethylamines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 13 Jan 1997 Discontinued-Preclinical for Cancer in United Kingdom (Unknown route)
- 06 Mar 1995 Preclinical development for Cancer in United Kingdom (Unknown route)